IP litigator Wesley Overson Jr. has joined Kilpatrick Townsend & Stockton after 25 years at Morrison & Foerster.

Overson practices across a broad range of technologies, including medical devices and biotechnology. Life sciences has been a challenging area for patents since the Supreme Court’s 2013 Association for Molecular Pathology v. Myriad Genetics decision, Overson said, but he thinks COVID-19 has provided a wake-up call about the importance of protecting inventions in areas such as diagnostics.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]